Weisler MD

  • Full Screen
  • Wide Screen
  • Narrow Screen
  • Increase font size
  • Default font size
  • Decrease font size

Dr. Weisler's Research

Dr. Weisler has been the principal investigator in over 200 clinical trials.  Dr. Weisler has authored or co-authored more than 60 journal articles and book chapters on bipolar disorder, attention deficit disorder, depression, PTSD, social phobia, dementia, pharmaco-economics, suicide, and generalized anxiety disorders.  In addition, he has been very actively involved as an investigator and /or consultant in the development of many of the currently approved and investigational treatments for bipolar disorder, major depression, attention deficit hyperactivity disorder, social phobia, posttraumatic stress disorder, generalized anxiety disorder, obsessive-compulsive disorder, dementia, sleep disorders and migraines. He has also conducted research in the areas of neuro-imaging and the genetics of psychiatric disorders. He has served as a peer reviewer for many scientific journals including Journal of the American Medical Association, Biological Psychiatry, Journal of Affective Disorders, and the Journal of Clinical Psychiatry among others, as well as for the Agency for Toxic Substances and Disease Registry (ATSDR)/Centers for Disease Control and Prevention (CDC).

 

Dr. Weisler’s research and work frequently have been featured on national television and radio shows, as well as in several magazines.  In 2006, a feature story in Oprah Magazine highlighted his group’s research into environmental chemical exposures and a potential link to suicides and cancers.  Dr. Weisler’s group’s groundbreaking research, which hypothesizes a possible environmental pollution link to death by suicide, was also covered by the national and international press.  Dr. Weisler is also credited with first identifying the usefulness of Lamictal® (lamotrigine) in bipolar disorder when, in 1993, he presented a report on his successful treatment on a compassionate use basis of two severely treatment-resistant bipolar patients with the then unapproved drug in the US for any condition. Dr. Weisler’s theory and clinical observations about Lamictal’s positive impact on depressive symptoms and mood cycling in those patients helped propel the ensuing research that led to Lamictal being approved in 2003 by the FDA as the first new drug for the maintenance treatment of bipolar disorder in 30 years.

 

Dr. Weisler and colleagues are currently working on a project with colleagues from ATSDR/CDC to improve recognition of and knowledge about disaster mental health for health care providers in the wake of the widespread mental health problems that followed Hurricanes Katrina and Rita.  The adverse mental health consequences seen in some emergency first responders and health providers following disasters are also being explored.

 

In January 2006 the Journal of the American Medical Association wrote a story about his and the group’s disaster mental health education efforts.  In August 2006 Dr. Weisler was the lead author of a Journal of the American Medical Association commentary article on Mental Health and Recovery in the Gulf Coast after Hurricanes Katrina and Rita.  News and magazine articles about the mental health issues raised in the commentary were then written by Newsweek, Time, Forbes, Science Weekly, and many newspapers in addition to being covered widely by the television media.

 

A very popular lecturer both nationally and internationally, he has presented well over a 1000 invited lectures, grand rounds and case conferences on topics related to psychiatric disorders and their treatment as well as the public health issues mentioned above. 

 

COPYRIGHT © 2010 Richard H. Weisler, M.D., P.A. All Rights Reserved.